<DOC>
<DOCNO>EP-0618201</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Thiadiazinones and their use in the treatment of cardiovascular or asthmatic conditions.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3154	A61K3154	A61P900	A61P908	A61P1100	A61P1100	A61P2500	A61P2524	A61P2526	A61P2528	A61P2900	A61P2900	A61P4300	A61P4300	C07D28500	C07D28516	C07D28518	C07D41700	C07D41704	C07D41706	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P9	A61P9	A61P11	A61P11	A61P25	A61P25	A61P25	A61P25	A61P29	A61P29	A61P43	A61P43	C07D285	C07D285	C07D285	C07D417	C07D417	C07D417	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Thiadiazinones of the formula I 
<
IMAGE
>
 in which Q is alkylene and R
<
5
>
 is an optionally cyclic amino group, show phosphodiesterase-inhibiting action and are suitable for treating cardiovascular and asthmatic conditions.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
</TEXT>
</DOC>
